Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation

Homoharringtonine (HHT), an inhibitor of protein synthesis, has been used to treat leukemia. Its therapeutic effects on non-small cell lung adenocarcinoma carrying KRAS mutation and their immune system are less understood. The present study examined the therapeutic efficacy and the immune effects of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Rep
Autores principales: Weng, Tzu-Yang, Wu, Hsuan Franziska, Li, Chung-Yen, Hung, Yu-Hsuan, Chang, Yu-Wei, Chen, Yi-Ling, Hsu, Hui-Ping, Chen, Yu-Hung, Wang, Chih-Yang, Chang, Jang-Yang, Lai, Ming-Derg
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5974086/
https://ncbi.nlm.nih.gov/pubmed/29844447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-26454-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares